SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-052922
Filing Date
2024-04-26
Accepted
2024-04-26 16:06:47
Documents
8
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242753-4_def14a.htm DEF 14A 766164
2 GRAPHIC lg_nextcure-4c.jpg GRAPHIC 17238
3 GRAPHIC sg_davidkabakoff-bw.jpg GRAPHIC 10576
4 GRAPHIC sg_michaelrichman-bw.jpg GRAPHIC 8426
5 GRAPHIC tbl_board-4c.jpg GRAPHIC 129886
6 GRAPHIC pc_diver-4c.jpg GRAPHIC 38770
7 GRAPHIC px_24nextcureproxy01pg01-bw.jpg GRAPHIC 226611
8 GRAPHIC px_24nextcureproxy01pg02-bw.jpg GRAPHIC 191509
  Complete submission text file 0001104659-24-052922.txt   1563893
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38905 | Film No.: 24883630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)